Key Personnel Acquisition Recently appointed experienced leadership positions like Chief Operating Officer and Chairman of the Board signal potential restructuring and strategic initiatives, presenting an opportunity to engage with new decision-makers and propose innovative solutions tailored to their vision for PetMeds.
Strategic Acquisition The acquisition of PetCareRx Inc for $36M opens avenues for cross-selling opportunities and showcases PetMeds' focus on expanding its product offerings, making it an ideal time to introduce complementary products and services that align with their newly diversified portfolio.
Product Expansion Pet Meds launching Nutrition and Supplements from Purina Pro Plan Veterinary Diets indicates a focus on enhancing their product line. This presents an opening to offer customizable solutions or exclusive partnerships that complement the new product range, catering to the evolving needs of PetMeds' customer base.
Revenue Growth Potential With revenue falling in the range of $10M - $50M, PetMeds sits in a profitable segment. Aiming to capitalize on their revenue potential, showcasing cost-effective solutions that improve operational efficiency or customer loyalty could resonate well with PetMeds' financial objectives.
Industry Expansion Opportunity Being a reputable player in Pharmaceutical Manufacturing, PetMeds holds opportunities for collaborating in research and development projects or introducing innovative technologies that streamline processes. Leveraging their industry standing can pave the way for entering new market segments and fostering long-term partnerships.
51
$10M$50M
11$10M
17K$1B
12K$1B
11$10M
100$10M$50M
4.2K$100M$1B
28K$1B| PetMeds® Email Formats | Percentage |
| FLast@1800petmeds.com | 87% |
| Last@1800petmeds.com | 4% |
| First.Last@1800petmeds.com | 4% |
| FirstLast@1800petmeds.com | 2% |
| First@1800petmeds.com | 2% |
| LFirst@1800petmeds.com | 1% |
| FLast@petmeds.com | 60% |
| Last@petmeds.com | 40% |
Pharmaceutical ManufacturingFlorida, United States201-500 Employees
PetMeds is a publicly traded company (NASDAQ: PETS). We deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. We serve millions of satisfied customers nationwide from one location.
Company Overview
Media & News
Funding & FinancialsPetMeds® has raised a total of $231K of funding over 1 rounds. Their latest funding round was raised on Nov 11, 2016 in the amount of $231K.
PetMeds® 's revenue is in the range of $10M$50M
Funding & FinancialsPetMeds® has raised a total of $231K of funding over 1 rounds. Their latest funding round was raised on Nov 11, 2016 in the amount of $231K.
PetMeds® 's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com